Benefits of Frameless Delivery and Fractionation Demonstrated in Favorable Response Rates and Hearing Preservation SUNNYVALE, Calif ., May 5 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that significant clinical data
--Accuray to Present CyberKnife Capabilities at Leading Urology Annual Meeting SUNNYVALE, Calif., April 23, 2009 /PRNewswire-FirstCall via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that more than 3,000 prostate cancer patients have
SUNNYVALE, Calif ., April 13 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that it will report results for its third quarter fiscal year 2009, ending March 28, 2009 on Tuesday, May 5, 2009 after the market closes.
--Attendance Doubles with More Than 200 Health Professionals From 28 Countries Participating SUNNYVALE, Calif., April 10, 2009 /PRNewswire-FirstCall via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that the second European
Newly Installed System at Apollo Hospital Treats Six and Preps Eight Patients in First Week SUNNYVALE, Calif ., April 3 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the first patients in India have been treated
Prior Studies Demonstrate Frequency of Prostate Motion, Supporting Need for the CyberKnife System's Real-Time Tracking to Spare Surrounding Sensitive Structures SUNNYVALE, Calif ., March 31 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery,
First Patients Treated in Yokohama, Japan Following Expanded Japanese Regulatory Approval SUNNYVALE, Calif ., March 19 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the first extracranial patients were treated in
SUNNYVALE, Calif ., March 2 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today significant growth in CyberKnife lung cancer treatments in calendar year 2008. The number of lung cancer patients treated with CyberKnife
CyberKnife Users' Meeting Highlights Clinical Studies and Emerging Trends in Brain, Lung and Prostate Radiosurgery SUNNYVALE, Calif ., Feb. 26 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced highlights from the clinical
--New Service Helps Customers to Treat More Patients Without Added Fixed Costs SUNNYVALE, Calif., Feb 20, 2009 /PRNewswire-FirstCall via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that 10 percent of its U.S.
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.